Bildkälla: Stockfoto

BioArctic Q3: Preparing for the next stage - Redeye

Redeye maintains its valuation of BioArctic and sees the company as an attractive long-term investment, with a solid innovation capability.

Redeye maintains its valuation of BioArctic and sees the company as an attractive long-term investment, with a solid innovation capability.
Börsvärldens nyhetsbrev
ANNONSER